Form 4: BioMarin Pharmaceutical Inc. Executive Henry J. Fuchs Reports Changes in Beneficial Ownership

Henry J. Fuchs, President of Worldwide R&D at BioMarin Pharmaceutical Inc., reports transactions involving the company's common stock, including acquisitions through the Employee Stock Purchase Plan and disposals to cover tax obligations.

Summary

• On April 30, 2024, Henry J. Fuchs acquired 300 shares of BioMarin Pharmaceutical Inc. common stock through the Employee Stock Purchase Plan at a price of $68.646 per share.
• On September 13, 2024, Fuchs disposed of 12,098 shares of common stock at a price of $84.9 per share.
• Following these transactions, Fuchs directly owns 185,074 shares of BioMarin Pharmaceutical Inc. common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as the transactions are routine and don't necessarily indicate a strong positive or negative outlook. The ESPP purchase is a slight positive, offset by the sale.

Positives

• The acquisition of shares through the Employee Stock Purchase Plan indicates confidence in the company's future.

Negatives

• The disposal of 12,098 shares could be perceived negatively, although it may be for tax obligations.

Risks

• Executive stock disposals can sometimes signal a lack of confidence, although this is not necessarily the case here.

Industry Context

Executive stock transactions are common and are closely watched by investors for signals about a company's prospects. Form 4 filings provide transparency into these transactions.

Comparison to Industry Standards

• Executive compensation packages often include stock options and employee stock purchase plans, aligning executive interests with shareholder value, similar to practices at companies like Amgen (AMGN) and Gilead Sciences (GILD).
• Stock disposal to cover tax obligations is a standard practice among executives, as seen in filings from executives at Regeneron (REGN) and Vertex Pharmaceuticals (VRTX).

Stakeholder Impact

• Shareholders may monitor these transactions for insights into management's view of the company's value.
• Employees participating in the Employee Stock Purchase Plan are directly impacted by the stock's performance.

Key Dates